Microfluidics Empowering Breast Cancer Drug Discovery
1. High-Throughput Drug Screening
Microfluidic chips allow researchers to miniaturize and multiplex drug screening platforms. This has enabled:
-
Rapid testing of cytostatic and small-molecule inhibitors across breast cancer subtypes.
-
Evaluation of drug resistance mechanisms in 3D tumor models and patient-derived cells.
-
Real-time imaging of cellular response to therapeutics under controlled microenvironments.
2. Nanoparticle & Liposome-Based Drug Delivery
Formulating drugs into nanoparticles or liposomes requires precision engineering—something microfluidics excels at. Applications include:
-
Consistent droplet formation for encapsulating cytostatic drugs.
-
Nanoparticle localization and transport within tumor-on-chip models.
-
Targeted delivery studies using organ-specific microfluidic platforms.
3. Monoclonal Antibody Screening & Extraction
Microfluidic immunoassays are revolutionizing antibody development:
-
On-chip antibody screening and affinity profiling.
-
Spatial localization of therapeutic antibodies in tumor-mimicking microchannels.
-
Integration with AI-driven image analysis for precision profiling.
🔬 New Frontiers in Immunotherapy & Virology
4. CAR-T Cell Profiling on Chip
CAR-T therapy demands high-resolution phenotyping and functional validation. Microfluidic systems support:
-
Profiling of engineered T-cells against breast cancer cells in co-culture chips.
-
Monitoring cytokine response and cytotoxicity in real time.
-
Miniaturized bioreactors for ex vivo CAR-T expansion and functional testing.
5. Virotherapy Monitoring and Optimization
Microfluidic platforms facilitate:
-
Visualization of oncolytic virus infection dynamics.
-
Quantification of viral load and bystander effects at single-cell level.
-
Safety assessment via controlled flow-based systems.
💉 Enabling Precision Vaccinology
Microfluidics is also making waves in vaccine research, enabling:
-
Controlled insertion of antigens (e.g., α-lactalbumin, MUC1 peptides) into delivery vectors.
-
Microdroplet-based synthesis of adjuvant formulations.
-
Multiplex immunogenicity testing using blood-on-chip platforms.
Our Expertise
At Microfluidic.Tech, we specialize in:
-
Laser-based bonding and sealing of microfluidic chips, including PC (polycarbonate) and hybrid materials.
-
Prototyping of custom organ-on-chip and tumor-on-chip platforms.
-
Collaborative development for drug screening, nanoparticle delivery, and immunotherapy assays.
We work closely with academic, clinical, and biotech partners to translate microfluidic innovation into real-world cancer solutions.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8877872/#sec3-micromachines-13-00152
